Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Meridian Bioscience (VIVO)

Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,488,837
  • Shares Outstanding, K 43,828
  • Annual Sales, $ 333,020 K
  • Annual Income, $ 42,460 K
  • 60-Month Beta 0.26
  • Price/Sales 4.47
  • Price/Cash Flow 19.13
  • Price/Book 4.04
Trade VIVO with:
  • Price/Earnings ttm 24.62
  • Earnings Per Share ttm 1.38
  • Most Recent Earnings $0.20 on 11/22/22
  • Latest Earnings Date 02/03/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.125 on 02/01/19
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 4.41%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.20
  • Number of Estimates 2
  • High Estimate 0.25
  • Low Estimate 0.15
  • Prior Year 0.35
  • Growth Rate Est. (year over year) -42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.20 +2.32%
on 01/03/23
34.02 -0.15%
on 01/30/23
+0.76 (+2.29%)
since 12/30/22
3-Month
31.14 +9.09%
on 12/09/22
34.02 -0.15%
on 01/30/23
+1.96 (+6.12%)
since 10/28/22
52-Week
20.35 +66.93%
on 02/01/22
34.38 -1.18%
on 07/06/22
+12.32 (+56.91%)
since 01/28/22

Most Recent Stories

More News
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD...

VIVO : 33.97 (unch)
DoubleVerify Holdings to Join S&P SmallCap 600

/PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P SmallCap 600 effective prior to the opening...

SPGI : 421.75 (-0.25%)
VIVO : 33.97 (unch)
DV : 33.92 (+2.51%)
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced...

VIVO : 33.97 (unch)
Meridian Bioscience (VIVO) Q4 Earnings Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VIVO : 33.97 (unch)
VERU : 0.5676 (-2.14%)
Meridian Bioscience: Fiscal Q4 Earnings Snapshot

Meridian Bioscience: Fiscal Q4 Earnings Snapshot

VIVO : 33.97 (unch)
Medtronic (MDT) Q2 Earnings Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 1.56% and 1.72%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

MDT : 83.66 (+0.11%)
VIVO : 33.97 (unch)
BellRing Brands (BRBR) Beats Q4 Earnings Estimates

BellRing Brands (BRBR) delivered earnings and revenue surprises of 6.90% and 6.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BRBR : 60.78 (+1.32%)
VIVO : 33.97 (unch)
VAREX IMAGING (VREX) Surpasses Q4 Earnings and Revenue Estimates

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 52.38% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VREX : 17.11 (-2.23%)
VIVO : 33.97 (unch)
Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Tops Revenue Estimates

Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -125% and 6.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

AAWH : 1.2000 (+3.45%)
VIVO : 33.97 (unch)
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -8% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 31.94 (-0.62%)
VIVO : 33.97 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed...

See More

Key Turning Points

3rd Resistance Point 34.11
2nd Resistance Point 34.06
1st Resistance Point 34.02
Last Price 33.97
1st Support Level 33.93
2nd Support Level 33.88
3rd Support Level 33.84

See More

52-Week High 34.38
Last Price 33.97
Fibonacci 61.8% 29.02
Fibonacci 50% 27.36
Fibonacci 38.2% 25.71
52-Week Low 20.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar